ACTIV-4b (Anti-Thrombotic Prevention Studies ACTIV-4) is a clinical trial to test the effectiveness of anti-thrombotic treatments in COVID-19 positive patients. ACTIV-4b is sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
